Disease-Modifying Treatments for Multiple Sclerosis Affect Measures of Cellular Immune Responses to EBNA-1 Peptides-Reference-Cited by-同舟云学术

Disease-Modifying Treatments for Multiple Sclerosis Affect Measures of Cellular Immune Responses to EBNA-1 Peptides

Published:2024-05 Issue:3 Volume:11 Page:
ISSN:2332-7812
Container-title:Neurology Neuroimmunology & Neuroinflammation
language:en
Short-container-title:Neurol Neuroimmunol Neuroinflamm

Author:

Dungan Lara¹^ORCID,Dunne Jean¹^ORCID,Savio Michael¹,Kalaszi Marianna¹^ORCID,McElheron Matt¹,Lynagh Yvonne¹,O'Driscoll Kate¹,Roche Carmel¹,Qureshi Ammara¹,Crowley Brendan¹,Conlon Niall¹,Kearney Hugh¹^ORCID

Affiliation:

1. From the Department of Immunology (L.D., J.D., N.C.), St James's Hospital; School of Medicine (M.S., N.C.), Trinity College Dublin; MS Unit (M.K., H.K.), Department of Neurology, St James's Hospital; Department of Medical Gerontology (M.M.), School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin; Virology Laboratory (Y.L., K.O.D., C.R., A.Q., B.C.), St James's Hospital; and FutureNeuro SFI Research Centre (H.K.), Academic Unit of Neurology, School of Medicine, Trinity...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/NXI.0000000000200217

Reference37 articles.

1. Multiple Sclerosis—A Review—Dobson—2019—European Journal of Neurology. Wiley Online Library. Accessed November 2, 2021. onlinelibrary.wiley.com/doi/full/10.1111/ene.13819

2. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

3. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM

4. Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis

5. Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy